{
    "2021-08-18": [
        [
            {
                "time": "",
                "original_text": "金域医学2021年中报点评：业绩增长超我们预期，特检业务与数字化转型稳步推进！【东吴医药朱国广团队】",
                "features": {
                    "keywords": [
                        "金域医学",
                        "2021年中报",
                        "业绩增长",
                        "特检业务",
                        "数字化转型"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "每日报告回放",
                "features": {
                    "keywords": [],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "太平洋维持金域医学买入评级：抗疫举措全面升级，重点疾病诊断业务快速发展",
                "features": {
                    "keywords": [
                        "金域医学",
                        "买入评级",
                        "抗疫举措",
                        "重点疾病诊断",
                        "快速发展"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "金域医学(603882)2021年中报点评：新冠检测规模扩大 常规项目恢复良好",
                "features": {
                    "keywords": [
                        "金域医学",
                        "603882",
                        "2021年中报",
                        "新冠检测",
                        "常规项目",
                        "恢复良好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "109股获券商买入评级，万盛股份目标涨幅达93.28%",
                "features": {
                    "keywords": [
                        "券商买入评级",
                        "万盛股份",
                        "目标涨幅",
                        "93.28%"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}